[go: up one dir, main page]

NO973242L - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti - Google Patents

Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti

Info

Publication number
NO973242L
NO973242L NO973242A NO973242A NO973242L NO 973242 L NO973242 L NO 973242L NO 973242 A NO973242 A NO 973242A NO 973242 A NO973242 A NO 973242A NO 973242 L NO973242 L NO 973242L
Authority
NO
Norway
Prior art keywords
gynecomastia
prophylaxis
physiological
preparation
treatment
Prior art date
Application number
NO973242A
Other languages
English (en)
Other versions
NO973242D0 (no
Inventor
Niels Korsgaard
Michael Shalmi
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO973242D0 publication Critical patent/NO973242D0/no
Publication of NO973242L publication Critical patent/NO973242L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse til- veiebringer nye anvendelser av forbin- delser med den generelle formel (I) a) hvor R\ R^ og R' uavhengig av hverandre er hydrogen, hydroksy, halogen,'tri- fluormetyl, lavere alkyl, lavere alk- oksy eller (tertiært amino)(lavere alk- oksy); og R^ og R^ uavhengig av hver- andre er hydrogen eller lavere alkyl, eller som et farmasøytisk akseptabelt salt derav, i kombinasjon med en farma- søytisk akseptabel bærer, til fremstil- ling av et farmasøytisk preparat for behandling eller profylakse av idio- patisk eller fysiologisk gynekomasti.
NO973242A 1995-01-13 1997-07-11 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti NO973242L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK4295 1995-01-13
DK77395 1995-06-30
PCT/DK1996/000012 WO1996021442A1 (en) 1995-01-13 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia

Publications (2)

Publication Number Publication Date
NO973242D0 NO973242D0 (no) 1997-07-11
NO973242L true NO973242L (no) 1997-07-11

Family

ID=26063181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973242A NO973242L (no) 1995-01-13 1997-07-11 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti

Country Status (12)

Country Link
US (1) US5919812A (no)
EP (1) EP0809496A1 (no)
JP (1) JPH10511960A (no)
CN (1) CN1168097A (no)
AU (1) AU702407B2 (no)
BR (1) BR9606754A (no)
CA (1) CA2208868A1 (no)
CZ (1) CZ212497A3 (no)
HU (1) HUP9800133A3 (no)
IL (1) IL116747A (no)
NO (1) NO973242L (no)
WO (1) WO1996021442A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117911A (en) 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP1794141B1 (en) 2004-09-21 2011-11-09 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US9708283B2 (en) 2010-11-01 2017-07-18 Mei Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
SI2953938T1 (en) 2014-02-07 2018-01-31 Novogen Ltd. Functionalized benzopyran compounds and their use
CN116139125A (zh) 2015-02-02 2023-05-23 梅制药公司 联合治疗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
BR9606754A (pt) 1998-01-06
US5919812A (en) 1999-07-06
JPH10511960A (ja) 1998-11-17
CA2208868A1 (en) 1996-07-18
MX9705218A (es) 1997-10-31
WO1996021442A1 (en) 1996-07-18
HUP9800133A3 (en) 1999-12-28
IL116747A0 (en) 1996-05-14
AU4329096A (en) 1996-07-31
HUP9800133A2 (hu) 1998-12-28
EP0809496A1 (en) 1997-12-03
CZ212497A3 (en) 1997-11-12
AU702407B2 (en) 1999-02-18
NO973242D0 (no) 1997-07-11
IL116747A (en) 1999-11-30
CN1168097A (zh) 1997-12-17

Similar Documents

Publication Publication Date Title
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
BR0109703A (pt) Derivados de piperazina
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
TR200102042T2 (tr) Spiro fropiridinlerin, tedavide faydalı yeni aralkil aminleri.
SE9903760D0 (sv) New compounds
SE9904505D0 (sv) Novel compounds
AP9701041A0 (en) Pyridylpyrrole compounds.
NO996108L (no) 9-oksinerytromycinderivater
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
AU2002239348A1 (en) Pyrazolopyridine derivatives
NO973243L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
NO971625L (no) Nye peptider med immunomodulatoriske effekter
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
NO991230L (no) Trisykliske forbindelser for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer
NO973342L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
PL326554A1 (en) Derivatives of amine and thiourea and inhibitors of nitrogen oxide synthase
NO973242L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
NO973340L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
DE69330601D1 (de) Serotoninergische ergolin derivate
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
NO973241L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b